Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain DXCM message board posts where the ticker symbol DXCM has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest DXCM SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000171 Size: 7 KB
2019-07-09
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000169 Size: 5 KB
2019-07-02
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000167 Size: 7 KB
2019-06-25
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000166 Size: 9 KB
2019-06-25
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000163 Size: 5 KB
2019-06-17
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000161 Size: 8 KB
2019-06-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000159 Size: 14 KB
2019-06-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000158 Size: 4 KB
2019-06-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000155 Size: 5 KB
2019-06-06
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-19-000153 Size: 14 KB
2019-06-04
More DXCM SEC Filings


Related news from
Tue, 16 Jul 2019
10:00:00 +0000
FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars
Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters. Abbott executives said the increase in manufacturing capacity will begin in the second half of this year and make room for the expected U.S. launch of the FreeStyle Libre 2. Abbott's plans for Libre, its fastest-growing diabetes product, used by 1.5 million people worldwide, will be in focus when the company reports quarterly earnings on Wednesday.
Mon, 15 Jul 2019
14:00:00 +0000
3 Top Diabetes Stocks to Watch in July
These three medtech companies are at the forefront of diabetes care.
Fri, 12 Jul 2019
17:06:05 +0000
3 Internet of Things Stocks to Buy for July
Today we've highlighted three, Zacks buy-ranked stocks with growing IoT businesses that investors might want to consider at the moment...
Thu, 11 Jul 2019
13:00:01 +0000
All You Need to Know About DexCom (DXCM) Rating Upgrade to Strong Buy
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Wed, 10 Jul 2019
00:15:02 +0000
Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $877,500 of Shares
President, CEO and Chairman of Dexcom Inc (NASDAQ:DXCM) Kevin R Sayer sold 6,000 shares of DXCM on 07/08/2019 at an average price of $146.25 a share.
Tue, 09 Jul 2019
16:22:04 +0000
Profit from Surprise in Q2 2019 Earnings Season
Profit from Surprise in Q2 2019 Earnings Season
Fri, 05 Jul 2019
13:25:01 +0000
Will MedTech Ease Investors' Concern & Outperform? 4 Picks
Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.
Wed, 03 Jul 2019
12:00:12 +0000
ETF & Stock Winners of Longest US Economic Expansion
The U.S. economy has stepped into the 11th year of the expansion, exhibiting the longest expansion in history. These winning ETFs and stocks will rally further.
Tue, 02 Jul 2019
13:00:00 +0000
Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time
DexCom, Inc. today announced that it plans to release its second quarter 2019 financial results after market close on Wednesday, July 31, 2019. Management will hold a conference call to review the company's second quarter 2019 performance starting at 4:30 p.m.
Wed, 26 Jun 2019
16:57:38 +0000
Need To Know: DexCom, Inc. (NASDAQ:DXCM) Insiders Have Been Selling Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Fri, 21 Jun 2019
20:10:15 +0000
IBD Stock Of The Day: Dexcom Nears Breakout On Medical Device Heyday
Dexcom is the IBD Stock Of The Day as the medical devices company flirts with a breakout on its tenth straight day of gains. Shares broke out above a buy point briefly and could try again.
Mon, 17 Jun 2019
21:52:02 +0000
Here’s What Hedge Funds Think About DexCom, Inc. (DXCM)
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades. Interest rates are paused at very low levels, and the risk of significant increases in the medium term seems low. Financing for transactions is freely available to good borrowers, […]
Mon, 17 Jun 2019
14:36:02 +0000
Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day
Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day
Mon, 17 Jun 2019
14:22:02 +0000
The Zacks Analyst Blog Highlights: JinkoSolar, Salem Media, Ciena, DexCom and Zumiez
The Zacks Analyst Blog Highlights: JinkoSolar, Salem Media, Ciena, DexCom and Zumiez
Fri, 14 Jun 2019
17:27:05 +0000
3 "Internet of Things" Stocks to Buy Right Now
Today we've highlighted three stocks with a Zacks Rank 2 (Buy) or better that could be poised for further IoT-based growth soon.
Fri, 14 Jun 2019
12:43:12 +0000
5 Top-Ranked Stocks Crushing the Market in June
Wall Street has staged a nice comeback from the May swoon on hopes of monetary easing policies.
Fri, 14 Jun 2019
12:09:00 +0000
Dexcom Looks Like It Can Finally Break Out on the Topside
For his "Executive Decision" segment of Mad Money Thursday night, Jim Cramer spoke with Kevin Sayer, chairman, president and CEO of Dexcom Inc. The trend-following Moving Average Convergence Divergence (MACD) oscillator just moved above the zero line for an outright buy signal on this time frame.
Mon, 10 Jun 2019
20:45:00 +0000
Why DexCom Stock Jumped Today
Good news for the company's G6 CGM system translated to a nice gain.
Mon, 10 Jun 2019
12:04:22 +0000
See what the IHS Markit Score report has to say about Dexcom Inc.
Dexcom Inc NASDAQ/NGS:DXCMView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for DXCM with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold DXCM had net inflows of $1.27 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Fri, 07 Jun 2019
12:26:12 +0000
DexCom and Companion Medical Collaboration to Support CGM
The collaboration enables InPen users to display real-time insulin data in Dexcom's (DXCM) CLARITY Diabetes Management Software.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is a site for sharing information about the atypical investments that the majority of investors have not discovered. It is about finding the next value/growth sector/investment before all the major houses on the Street are recommending it." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2019, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards